Company Beijing Luzhu Biotechnology Co., Ltd.

2480

CNE100005YD8

Pharmaceuticals

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:10 2024-05-21 am EDT			5-day change	1st Jan Change
24.5 ^HKD	+0.41%		-7.55%	-18.06%

May. 07	59,729,296 Domestic Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI
May. 07	132,333,736 H Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI

Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.

Number of employees: 133

Managers	Title	Age	Since
Jian Kong CEO	Chief Executive Officer	61	01-12-31
Hui Zhang DFI	Director of Finance/CFO	56	-
Ling Peng CHM	Chairman	43	18-12-10
Xian Min Jiang CTO	Chief Tech/Sci/R&D Officer	61	13-07-18
Yan Ping Zhang BRD	Director/Board Member	-	13-06-27
Ho Yan Lai SEC	Corporate Secretary	-	22-06-17
Si Yu Liu SEC	Corporate Secretary	33	21-08-31

Members of the board	Title	Age	Since
Wai Yip Leung BRD	Director/Board Member	47	23-03-29
Biao Ma BRD	Director/Board Member	60	19-08-25
Ai Jun Hou BRD	Director/Board Member	58	-
Yan Ping Zhang BRD	Director/Board Member	-	13-06-27
Jian Kong CEO	Chief Executive Officer	61	01-12-31
Xian Min Jiang CTO	Chief Tech/Sci/R&D Officer	61	13-07-18
Shuang Quan Kong BRD	Director/Board Member	50	19-08-25
Ling Peng CHM	Chairman	43	18-12-10
Xi Kong BRD	Director/Board Member	31	14-07-20
Li Ang Chen BRD	Director/Board Member	44	22-04-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	59,729,296	0	0	8.669 %
Stock B	1	142,719,736	17,550,933 ( 12.30 %)	0

Name	Equities	%	Valuation
Beijing E Town Sun Fund Management Co ltd 18.76 %	37,969,696	18.76 %	136 M $
Yan Ping Zhang 9.978 %	20,200,000	9.978 %	72 M $
BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD. 6.793 %	13,751,500	6.793 %	49 M $
Zhuhai Hengqin Luzhu Enterprise Management Partnership LP 6.079 %	12,307,500	6.079 %	44 M $
CCB International (China) Co., Ltd. 5.761 %	11,664,075	5.761 %	42 M $
Herui Venture Capital Fund Management (Shenzhen) Co. Ltd. 4.940 %	10,000,744	4.940 %	36 M $
Jinjiang Zhenrui Equity Investment Aprtnership LP 3.841 %	7,776,050	3.841 %	28 M $
Xian Min Jiang 1.976 %	4,000,000	1.976 %	14 M $
Xi Kong 0.2717 %	550,000	0.2717 %	2 M $

Name	Equities	%	Valuation
Jian Kong 28.79 %	58,294,513	28.79 %	209 M $

Beijing Lüzhu Biotechnology Co., Ltd.

3 Guangtong Street Industrial Development Zone

101113, Beijing

http://www.luzhubiotech.com

address Beijing Luzhu Biotechnology Co., Ltd.(2480)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.71 CNY

Average target price

27.73 CNY

Spread / Average Target

+22.09%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
BEIJING LUZHU BIOTECHNOLOGY CO., LTD.	-18.06%	633M
CSL LIMITED	-3.15%	89.69B
SAMSUNG BIOLOGICS CO.,LTD.	+2.50%	41.34B
BIOGEN INC.	-12.01%	33.72B
UCB	+62.74%	26.11B
BIOMARIN PHARMACEUTICAL INC.	-19.79%	14.63B
INCYTE CORPORATION	-8.58%	12.84B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.34%	11.66B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.92%	11.52B
SWEDISH ORPHAN BIOVITRUM AB	+4.27%	8.92B

Biopharmaceuticals